
(ASX CODE: PAA) – Dr Richard Mollard, Chief Scientific Officer of clinical stage drug developer, Pharm-Aust, presented at the Broker Briefing September Tech & Biotech Investor Webinar.
https://www.pharmacytechcareers.com/pharm-aust-asxpaa-broker-briefing-tech-biotech-investor-webinar-september-2021/
No comments:
Post a Comment